Hematology diagnostics market to reach USD 11.9B by 2030

The “Hematology diagnostics: Global strategic business report” report has been added to ResearchAndMarkets.com’s offering.

Global hematology diagnostics market to reach $11.9 billion by 2030
The global market for hematology diagnostics estimated at US$7.6 billion in the year 2022, is projected to reach a revised size of US$11.9 billion by 2030, growing at a CAGR of 5.7% over the analysis period 2022-2030.

The analysis covers various aspects of the market, including blood count, platelet function, hemoglobin, hematocrit, and their applications in hospitals, diagnostic laboratories, and other end-uses. It also includes an assessment of the market for consumables and instruments used in hematology diagnostics.

Consumables, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$7.8 billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 6.6% CAGR for the next 8-year period.

The U.S. market is estimated at $2.1 billion, while China is forecast to grow at 9.2% CAGR
This report provides a comprehensive analysis of the global hematology diagnostics market, covering recent, current, and future trends across various geographic regions, including the USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

The hematology diagnostics market in the U.S. is estimated at US$2.1 billion in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$2.7 billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2022 to 2030.

It presents independent assessments of annual sales in US$ million for the years 2022 through 2030, along with corresponding percentage Compound Annual Growth Rates (CAGRs). Historical data from 2014 to 2021 is included for reference, offering insights into market dynamics over time. Additionally, a 16-year perspective is provided, breaking down value sales percentages for select years (2014, 2023, and 2030) to facilitate a comprehensive understanding of the hematology diagnostics market.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Focus on select players (Total 43 featured)

• Abbott Laboratories
• Beckman Coulter, Inc.
• F. Hoffmann-La Roche AG
• Mindray Medical International Ltd.
• Siemens Healthineers
• Sysmex Corporation

Research and Markets